Publicacions en col·laboració amb investigadors/es de Hospital Ramón y Cajal (12)

2022

  1. Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain

    Cancer Epidemiology, Vol. 76

2021

  1. Granulomas in Dermatopathology: Principal Diagnoses - Part 1

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 682-704

  2. Granulomas in Dermatopathology: Principal Diagnoses — Part 2

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 8, pp. 705-724

2020

  1. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2018

  1. Nilotinib as coadjuvant treatment with doxorubicin in patients with sarcomas: A phase i trial of the Spanish group for research on sarcoma

    Clinical Cancer Research, Vol. 24, Núm. 21, pp. 5239-5249

2016

  1. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)

    Nefrologia, Vol. 36, Núm. 3, pp. 255-267

2015

  1. Biointegration of corneal macroporous membranes based on poly(ethyl acrylate) copolymers in an experimental animal model

    Journal of Biomedical Materials Research - Part A, Vol. 103, Núm. 3, pp. 1106-1118

2011

  1. Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico

    Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48

  2. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 636-651

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2004

  1. Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

    Journal of Neuro-Oncology, Vol. 70, Núm. 3, pp. 359-370

2000

  1. Differential effects of acute and chronic hyperammonemia on signal transduction pathways associated to NMDA receptors

    Neurochemistry International, Vol. 37, Núm. 2-3, pp. 249-253